|
|
|
|
| LEADER |
01686nam a2200313 u 4500 |
| 001 |
EB001999995 |
| 003 |
EBX01000000000000001162896 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 020 |
|
|
|a 158763144X
|
| 020 |
|
|
|a 9781587631443
|
| 100 |
1 |
|
|a Balk, Ethan
|
| 245 |
0 |
0 |
|a Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease
|h Elektronische Ressource
|c prepared for Agency for Healthcare Research and Quality ; prepared by Tufts-New England Medical Center EPC ; investigators, Ethan Balk ... [et al.]
|
| 260 |
|
|
|a Rockville, Md.
|b U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality
|c 2004, [2004]
|
| 300 |
|
|
|a xiii, 169 p.
|b ill.
|c 28 cm
|
| 505 |
0 |
|
|a Includes bibliographical references (p. 117-165)
|
| 653 |
|
|
|a Risk Factors / https://id.nlm.nih.gov/mesh/D012307
|
| 653 |
|
|
|a Evidence-Based Medicine / methods / https://id.nlm.nih.gov/mesh/D019317Q000379
|
| 653 |
|
|
|a Cardiovascular Diseases / drug therapy / https://id.nlm.nih.gov/mesh/D002318Q000188
|
| 653 |
|
|
|a Fatty Acids, Omega-3 / therapeutic use / https://id.nlm.nih.gov/mesh/D015525Q000627
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 710 |
2 |
|
|a Tufts-New England Medical Center
|b Evidence-based Practice Center
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a AHRQ publication
|
| 500 |
|
|
|a "March 2004.". - "Contract No. 290-02-0022."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK37239
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|